NatureWise Biotech & Medicals Corporation

TPEX:4732 Voorraadrapport

Marktkapitalisatie: NT$1.2b

NatureWise Biotech & Medicals Inkomsten in het verleden

Verleden criteriumcontroles 2/6

NatureWise Biotech & Medicals's earnings have been declining at an average annual rate of -15.3%, while the Personal Products industry saw earnings growing at 11.2% annually. Revenues have been declining at an average rate of 9% per year. NatureWise Biotech & Medicals's return on equity is 2.2%, and it has net margins of 7%.

Belangrijke informatie

-15.3%

Groei van de winst

-18.8%

Groei van de winst per aandeel

Personal Products Groei van de industrie13.9%
Inkomstengroei-9.0%
Rendement op eigen vermogen2.2%
Nettomarge7.0%
Laatste winstupdate30 Jun 2024

Recente prestatie-updates uit het verleden

Here's Why We Don't Think NatureWise Biotech & Medicals's (GTSM:4732) Statutory Earnings Reflect Its Underlying Earnings Potential

Dec 20
Here's Why We Don't Think NatureWise Biotech & Medicals's (GTSM:4732) Statutory Earnings Reflect Its Underlying Earnings Potential

Recent updates

Lacklustre Performance Is Driving NatureWise Biotech & Medicals Corporation's (GTSM:4732) Low P/E

Apr 29
Lacklustre Performance Is Driving NatureWise Biotech & Medicals Corporation's (GTSM:4732) Low P/E

A Look At The Intrinsic Value Of NatureWise Biotech & Medicals Corporation (GTSM:4732)

Mar 25
A Look At The Intrinsic Value Of NatureWise Biotech & Medicals Corporation (GTSM:4732)

Here's Why We Don't Think NatureWise Biotech & Medicals's (GTSM:4732) Statutory Earnings Reflect Its Underlying Earnings Potential

Dec 20
Here's Why We Don't Think NatureWise Biotech & Medicals's (GTSM:4732) Statutory Earnings Reflect Its Underlying Earnings Potential

Opbrengsten en kosten

Hoe NatureWise Biotech & Medicals geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

TPEX:4732 Opbrengsten, kosten en inkomsten (TWD Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 24225165957
31 Mar 24192135643
31 Dec 23160105430
30 Sep 23170135432
30 Jun 23180165334
31 Mar 23205235442
31 Dec 22229305449
30 Sep 22261465355
30 Jun 22293635261
31 Mar 22271475165
31 Dec 21250315069
30 Sep 21223154973
30 Jun 2119704876
31 Mar 21252335372
31 Dec 20307655768
30 Sep 20330706169
30 Jun 20354766469
31 Mar 20331586076
31 Dec 19307405684
30 Sep 19251195277
30 Jun 19195-24970
31 Mar 19152-94654
31 Dec 18108-154337
30 Sep 1899-194137
30 Jun 1890-233936
31 Mar 1879-423945
31 Dec 1769-603955
30 Sep 1765-673858
30 Jun 1761-743761
31 Mar 1759-673759
31 Dec 1658-603656
30 Sep 1654-463550
30 Jun 1651-323544
31 Mar 1651-303440
31 Dec 1550-293235
30 Sep 1548-303329
30 Jun 1545-313322
31 Mar 1546-293517
31 Dec 1448-263612
30 Sep 1452-233610
30 Jun 1457-20368
31 Mar 1461-16409
31 Dec 1365-124310

Kwaliteitswinsten: 4732 has high quality earnings.

Groeiende winstmarge: 4732's current net profit margins (7%) are lower than last year (8.8%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: 4732 has become profitable over the past 5 years, growing earnings by -15.3% per year.

Versnelling van de groei: 4732's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Winst versus industrie: 4732 had negative earnings growth (-1%) over the past year, making it difficult to compare to the Personal Products industry average (-1%).


Rendement op eigen vermogen

Hoge ROE: 4732's Return on Equity (2.2%) is considered low.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden